International Stem Cell CORP (ISCO) KPIs and segments
Close on Oct 19, 2026Market cap $2.27MP/E –Yield –
KPIs & segments
Operating metrics and segments that drive International Stem Cell's business
International Stem Cell's revenue by segment, product and region, plus the counts and sizes it tags in its 10-K and 10-Q filings (XBRL). Each figure links to the filing it came from. A fuller KPI sheet built from earnings releases and presentations is on the way. See the segment tables for a trailing-twelve-month view, or how companies compare on operating metrics.
The chart is empty. Tick the box next to any metric in the table below to plot it — tick several to compare them on one chart.
| Add to chart | Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Biomedical Market($M)3 | 2.52 | 2.17 | 2 | 2.20 | 2.30 | 2.00 | 2.25 | 2 | 2.12 | 1.92 | 1.59 | 1.79 | |
Media($M) | 1.96 | 1.32 | 1.52 | 1.46 | 1.55 | 1.28 | 1.44 | 1.50 | 1.55 | 1.47 | 1.14 | 1.36 | |
Cells($M) | 0.57 | 0.85 | 0.48 | 0.75 | 0.76 | 0.71 | 0.81 | 0.50 | 0.57 | 0.46 | 0.45 | 0.43 | |
Quality Control Testing Services($M) | 0 | 0 | 0 | 0 | |||||||||
Anti-aging Market($M) | 0.15 | 0.15 | 0.16 | 0.17 | 0.14 | 0.13 | 0.20 | 0.18 | 0.21 | 0.21 | 0.30 | 0.19 | |
Anti-Aging Skincare Market($M) | 0.15 | 0.15 | 0.16 | 0.17 | 0.14 | 0.13 | 0.20 | 0.18 | 0.21 | 0.21 | 0.30 | 0.19 | |
United States($M) | 2.22 | 1.95 | 1.70 | 1.85 | 1.94 | 1.78 | 1.87 | 1.66 | 1.80 | 1.63 | 1.33 | 1.44 | |
International($M) | 0.30 | 0.22 | 0.30 | 0.35 | 0.37 | 0.22 | 0.37 | 0.34 | 0.33 | 0.29 | 0.26 | 0.34 | |
Biomedical Market($M) | 0.74 | 0.59 | 0.46 | 0.75 | 0.90 | 0.67 | 0.80 | 0.64 | 0.86 | 0.70 | 0.37 | 0.66 | |
Anti-aging Market($M) | -0.09 | -0.10 | -0.13 | -0.09 | -0.09 | -0.21 | -0.13 | -0.13 | -0.15 | -0.20 | -0.07 | -0.14 | |
Therapeutic Market($M) | -0.68 | -0.68 | -0.65 | -0.57 | -0.64 | -0.67 | -0.61 | -0.60 | -0.56 | -0.68 | -0.72 | -0.62 | |
Biomedical Market($M) | 1.34 | 1.26 | 0.98 | 1.19 | 1.38 | 1.11 | 1.31 | 1.08 | 1.31 | 1.14 | |||
Anti-aging Market($M) | 0.12 | 0.11 | 0.11 | 0.13 | 0.15 | 0.02 | 0.14 | 0.13 | 0.11 | 0.10 | |||
Earlier reporting (last reported 2024)3 | |||||||||||||
16 metrics have no data in the last 12 quarters — .
Italic numbers are calculated by StockData from reported figures (hover for the formula). Numbers with a dotted underline are read from the text of earnings releases and presentations; hover to see the exact sentence. Tick a row to add it to the chart above (up to 8 lines).
Methodology and excluded metrics
- Core rows come from the segment and revenue-disaggregation notes of 10-K and 10-Q filings (XBRL), linked to each filing. Fourth-quarter figures are the fiscal year less the first nine months (shown in italic).
Data updated 2026-08-13.
See a number that looks wrong?